+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Animal Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Animal Type (Aqua, Companion, Poultry) - Forecast 2024-2030

  • PDF Icon

    Report

  • 191 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5317900
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Animal Vaccines Market size was estimated at USD 16.39 billion in 2023, USD 17.75 billion in 2024, and is expected to grow at a CAGR of 8.34% to reach USD 28.72 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Animal Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH by SAN Group, Biogénesis Bagó S.A., Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd., Dalan Animal Health., Eli Lilly and Company, Endovac Animal Health, LLC, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., Indian Immunologicals Limited, Merck KGaA, Neogen Corporation, Pfizer Inc., Phibro Animal Health Corporation, Sanofi S.A., Torigen Pharmaceuticals Inc., Vaxxinova GmbH, VEROVACCiNES GmbH, Vetigenics, Vetoquinol SA, Virbac, Inc., and Zoetis Inc.

Market Segmentation & Coverage

This research report categorizes the Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Attenuated Live Vaccines
    • DNA Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • Subunit Vaccines
  • Animal Type
    • Aqua
      • Aeromonas
      • Streptococcosis
      • Vibrio
    • Companion
      • Canine
        • Canine Herpes
        • Distemper
        • Kennel Cough
        • Lyme Disease
        • Parvovirus
        • Rabies Canine
      • Feline
        • Calicivirus
        • Coronavirus Feline
        • Panleukopenia
        • Rabies Feline
        • Rhinotracheitis
    • Poultry
      • Avian Influenza
      • Infectious Bronchitis
      • Marek's Disease
      • Newcastle Disease
      • Salmonella
    • Ruminants
      • Coronavirus Ruminants
      • E. Coli
      • Foot & mouth disease (FMD)
      • Lumpy skin
      • Rotavirus
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Animal Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the Animal Vaccines Market?
  4. What is the market share of the leading vendors in the Animal Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the Animal Vaccines Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Animal Vaccines Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Livestock Population
5.1.1.2. Rising Animal Husbandry along with Commercialization of Animal Products
5.1.1.3. Increasing Incidences of Zoonotic Diseases
5.1.2. Restraints
5.1.2.1. Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
5.1.3. Opportunities
5.1.3.1. Shift from Live Attenuated Vaccines to DNA Vaccines
5.1.3.2. Continuous Technological Advancements in Vaccines
5.1.4. Challenges
5.1.4.1. Adverse Impacts of Vaccines
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Animal Vaccines Market, by Product
6.1. Introduction
6.2. Attenuated Live Vaccines
6.3. DNA Vaccines
6.4. Inactivated Vaccines
6.5. Recombinant Vaccines
6.6. Subunit Vaccines
7. Animal Vaccines Market, by Animal Type
7.1. Introduction
7.2. Aqua
7.3.1. Aeromonas
7.3.2. Streptococcosis
7.3.3. Vibrio
7.3. Companion
7.4.1. Canine
7.4.2.1. Canine Herpes
7.4.2.2. Distemper
7.4.2.3. Kennel Cough
7.4.2.4. Lyme Disease
7.4.2.5. Parvovirus
7.4.2.6. Rabies Canine
7.4.2. Feline
7.4.3.1. Calicivirus
7.4.3.2. Coronavirus Feline
7.4.3.3. Panleukopenia
7.4.3.4. Rabies Feline
7.4.3.5. Rhinotracheitis
7.4. Poultry
7.5.1. Avian Influenza
7.5.2. Infectious Bronchitis
7.5.3. Marek's Disease
7.5.4. Newcastle Disease
7.5.5. Salmonella
7.5. Ruminants
7.6.1. Coronavirus Ruminants
7.6.2. E. Coli
7.6.3. Foot & mouth disease (FMD)
7.6.4. Lumpy skin
7.6.5. Rotavirus
8. Americas Animal Vaccines Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Animal Vaccines Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Animal Vaccines Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Anicon Labor GmbH by SAN Group
12.1.2. Biogénesis Bagó S.A.
12.1.3. Boehringer Ingelheim International GmbH
12.1.4. Brilliant Bio Pharma Private limited
12.1.5. Ceva Santé Animale
12.1.6. China Animal Husbandry Industry Co., Ltd.
12.1.7. Dalan Animal Health.
12.1.8. Eli Lilly and Company
12.1.9. Endovac Animal Health, LLC
12.1.10. Heska Corporation
12.1.11. Hester Biosciences Limited
12.1.12. HIPRA, S.A.
12.1.13. Indian Immunologicals Limited
12.1.14. Merck KGaA
12.1.15. Neogen Corporation
12.1.16. Pfizer Inc.
12.1.17. Phibro Animal Health Corporation
12.1.18. Sanofi S.A.
12.1.19. Torigen Pharmaceuticals Inc.
12.1.20. Vaxxinova GmbH
12.1.21. VEROVACCiNES GmbH
12.1.22. Vetigenics
12.1.23. Vetoquinol SA
12.1.24. Virbac, Inc.
12.1.25. Zoetis Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. ANIMAL VACCINES MARKET RESEARCH PROCESS
FIGURE 2. ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANIMAL VACCINES MARKET DYNAMICS
FIGURE 7. ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 10. ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Anicon Labor GmbH by SAN Group
  • Biogénesis Bagó S.A.
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private limited
  • Ceva Santé Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dalan Animal Health.
  • Eli Lilly and Company
  • Endovac Animal Health, LLC
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA, S.A.
  • Indian Immunologicals Limited
  • Merck KGaA
  • Neogen Corporation
  • Pfizer Inc.
  • Phibro Animal Health Corporation
  • Sanofi S.A.
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova GmbH
  • VEROVACCiNES GmbH
  • Vetigenics
  • Vetoquinol SA
  • Virbac, Inc.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information